Biotech recent insider selling: Arena Pharmaceuticals (NASDAQ:ARNA), Questcor Pharmaceuticals (NASDAQ:QCOR), Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ), Illumina (NASDAQ:ILMN)

Arena Pharmaceuticals (NASDAQ:ARNA) Director Tina Susan Nova sold 35,000 shares of Arena Pharmaceuticals stock in a transaction dated Monday, April 14th. The stock was sold at an average price of $6.22, for a total transaction of $217,700.00. Following the sale, the director now directly owns 18,728 shares of the company’s stock, valued at approximately $116,488.. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares after opening at $6.40 moved to $6.44 on last trade day and at the end of the day closed at $6.30. Company price to sales ratio in past twelve months was calculated as 16.97 and price to cash ratio as 6.23. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) showed a negative weekly performance of -3.96%.

Questcor Pharmaceuticals (NASDAQ:QCOR) CEO Don Bailey sold 40,000 shares of Questcor Pharmaceuticals stock on the open market in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $79.65, for a total transaction of $3,186,000.00.Questcor Pharmaceuticals Inc (NASDAQ:QCOR) shares advanced 0.19% in last trading session and ended the day on $78.46. QCOR return on equity ratio is recorded as 94.20% and its return on assets is 50.60%. Questcor Pharmaceuticals Inc (NASDAQ:QCOR) yearly performance is 183.86%.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) CMO Jeffrey K. Tobias unloaded 3,000 shares of Jazz Pharmaceuticals plc stock on the open market in a transaction that occurred on Monday, April 14th. The shares were sold at an average price of $128.54, for a total transaction of $385,620.00. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) shares moved up 3.96% in last trading session and was closed at $136.10, while trading in range of $ 129.84 – 136.95. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) year to date (YTD) performance is 7.54%.

Illumina (NASDAQ:ILMN) CFO Marc Stapley unloaded 1,422 shares of Illumina stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $134.80, for a total transaction of $191,685.60. Following the sale, the chief financial officer now directly owns 21,996 shares in the company, valued at approximately $2,965,061.Illumina, Inc. (NASDAQ:ILMN) weekly performance is -6.60%. On last trading day company shares ended up $136.22. Illumina, Inc. (NASDAQ:ILMN) distance from 50-day simple moving average (SMA50) is -13.99%. Analysts mean target price for the company is $166.40.